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Highlights 
 MRSA clones with a low chlorhexidine MIC phenotype can still survive 
decolonization regimes 
 in vivo decolonization tolerance of ST239-TW may not be due to the presence of 
qacA alone 
 elevated fibrinogen and fibronectin binding by ST239-TW is indicative of increased 
cell uptake 
 ST239-TW shows increased chlorhexidine survival when adhered and internalized 
to keratinocytes 
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ABSTRACT 
 
Information on genetic determinants of chlorhexidine tolerance (qacA carriage and 
MIC) in vitro is available, although evidence of the clinical impact and mechanisms 
remain poorly understood. We investigated why, following chlorhexidine intervention, 
prevalent epidemic MRSA ST22 and ST36 clones declined at an ICU, whilst an 
ST239-TW clone did not. The chlorhexidine tolerant ST239-TW phenotypes were 
assessed for their protein binding, cell adhesion and intracellular uptake potential. 
Methods 
Six ST22, ST36 and ST239-TW bloodstream infection isolates with comparable 
chlorhexidine MICs were selected from a 2-year outbreak in an ICU at Guy’s and St. 
Thomas’ Hospital. Isolates were tested for fibrinogen and fibronectin binding, and 
adhesion/internalization into human keratinocytes with and without biocide. 
Results 
Binding to fibrinogen and fibronectin, adhesion and intracellular uptake within 
keratinocytes (P < 0.001) and intracellular survival in keratinocytes under 
chlorhexidine pressure (ST22 3.18%, ST36 4.57% vs ST239-TW 12.79%;  
P < 0.0001) was consistently higher for ST239-TW.  
Conclusions 
We present evidence that MRSA clones with similarly low in vitro tolerance to 
chlorhexidine exhibit different in vivo susceptibilities. The phenomenon of S. aureus 
adhesion and intracellular uptake into keratinocytes could therefore be regarded as 
an additional mechanism of chlorhexidine tolerance, enabling MRSA to evade 
infection control measures. 
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intracellular uptake, biocide evasion  
 
INTRODUCTION 
Over the past 20 years there have been two dominant pandemic healthcare-
associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones in the UK, 
EMRSA–15 (ST22) and EMRSA-16 (ST36), with lower prevalence of other clones 
(ST8, ST239, ST5 and ST247). HA-MRSA rates have decreased significantly since 
the mid-2000’s 1–4 following the introduction of a comprehensive UK-wide infection 
control program comprising re-enforcement of basic infection control practices and 
targeted measures of screening, contact precautions, patient isolation and 
decolonization.4–7 We previously reported an approximate 70% reduction in 
transmission of endemic MRSA clones following introduction of chlorhexidine-based 
universal decolonization into the intensive care unit (ICU) at Guy’s and Thomas' 
Hospital (GSTT), London in 2004.4 This is consistent with a number of studies 
reporting reductions in MRSA transmission, bacteremia and colonization following 
introduction of universal chlorhexidine skin washes.8–10 
 
Introduction of heightened infection control measures also uncovered a hidden two-
year outbreak due to an ST239 clone (ST239-TW) which probably originated from 
Singapore and is one of five major ST239 clades (the Thai clade).11 While 
transmission of ST22 and ST36 clones decreased following the introduction of 
decolonization with chlorhexidine on the GSTT ICU, the transmission of ST239-TW 
did not.4,8,12–14 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
We previously reported that ST239-TW had an increase in chlorhexidine MBC 
compared with non-TW MRSA isolates (ST22 and ST36), based on analysis of five 
skin isolates identified during the outbreak.8 MRSA blood stream infection (BSI) 
isolates from the same outbreak were analyzed for their CHG (chlorhexidine 
digluconate) MIC in 2013, reportedly clustering into MICs groups of < 2 mg/l and ≥ 2 
mg/l.12 ST239-TWs isolated during that outbreak all carry the plasmid borne qacA 
gene, which encodes a major facilitator superfamily efflux-pump that expels 
quaternary ammonium compounds and biguanides such as chlorhexidine, and has 
been associated with biocide tolerance. Carriage of qacA currently represents the 
accepted explanation for the lack of clinical effect of chlorhexidine on 
Staphylococci.15–17 However, small increases in staphylococcal MICs or MBCs have 
been reported elsewhere, for which a correlation with qacA/B carriage was found to 
be equivocal, or otherwise associated with a modest one dilution increase in MIC, 
but with no effect on the MBC.18–22 Given that there is no internationally endorsed 
standard for assessing biocide MICs and MBCs, except for the CLSI guideline 
(biocide activity measurement)21 and no epidemiological breakpoints for the 
resistance of the test organism (BSAC, EUCAST or CLSI), the significance of these 
increases is unclear; particularly since surface acting biocides are typically applied in 
much higher concentrations than their in vitro MIC or MBC.23–25 Following the 2009 
report on Antibiotic Resistance Effects of Biocides by the Scientific Committee on 
Emerging and Newly Identified Health Risks26 Morrissey et al. established in 2014 
the first epidemiological breakpoints characterizing S. aureus chlorhexidine 
resistance, setting the chlorhexidine MIC ECOFF at 8 mg/ml and the MBC ECOFF at 
>64 mg/ml.27 Despite working on a similar size S. aureus strain collection, Furi et al. 
were not able to set such breakpoints.21 
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One potential alternative survival mechanism to antimicrobials in bacteria is that of 
evading topical biocide action by invading human epithelial cells and hiding in an 
intracellular location. Indeed, staphylococcal adhesion, invasion and persistence has 
been observed in multiple human cell types (by professional and non-professional 
phagocytosis) and has been demonstrated as a means of evading the host innate 
immunity, also fostering deeper tissue and systemic infections, in addition to being 
postulated as a mode of surviving antibiotic action.28–33 
 
S. aureus adhesion and internalization to human endothelial and epithelial cells via 
binding to fibrinogen and fibronectin has been widely studied,34–38 and has to be 
included when investigating bacterial invasion into host cells. The fact that blood 
stream infection (BSI) isolates of ST239-TW with moderate chlorhexidine 
susceptibilities can persist after topical decolonization and thus outlive other clones 
requires detailed examination.4,8,13,38 We therefore sought to investigate whether 
ST239-TW isolates present with a biocide evasion strategy, based on a dominant 
keratinocyte adhesion and internalization phenotype and if this a plausible alternative 
mechanism of decolonization tolerance over other MRSA clones. 
 
METHODS 
Bacterial strains and growth conditions 
A representative collection of six ST36 (three qacA+ and three qacA-), six ST22 
(three qacA+ and three qacA-) and six ST239-TW isolates (all qacA+; no qacA- strain 
initially isolated) were selected from a previously published strain set of 136 MRSA 
bloodstream infection isolates (BSI), from GSTT ICU patients between 2001 and 
2009 (Supplementary Material Tables S1-3).12 The strains were chosen based on 
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their previously established, comparable and highly susceptible CHG MIC result (all 
<2 mg/l; Supplementary Material Table S4).  
BSI strain characteristics are stated in the Supplementary Material (Tables S1-3). 
S. aureus NCTC 10788, a standard strain for chemical disinfection testing, was 
obtained from Public Health England and used as a quality control strain in CHG 
susceptibility testing.  
 
In vitro chlorhexidine digluconate susceptibility testing 
MICs were determined using a modified Clinical and Laboratory Standard Institute 
(CLSI) micro-dilution method, 40 with adaptions described by Longtin et al. (2011).41 
A 2-fold serial dilution was prepared from a 20% (w/v) chlorhexidine digluconate 
stock solution (CHG) (Sigma-Aldrich, Ltd. UK) and final concentrations of 64 to 0.125 
mg/l were tested against 5 x 105 CFU/ml bacteria suspensions. 
 
Bacterial binding to human immobilized fibrinogen and fibronectin 
The adherence assay was performed using 10 μg/ml human fibrinogen or fibronectin 
(Merck Chemicals Ltd, UK). Aliquots of 100 µL stationary or exponential phase 
bacterial cultures were added to protein coated wells and incubated for 2 hours at 
37°C. Bound bacteria were fixed with 25% formaldehyde and then stained with 0.1% 
crystal violet. Absorbance was measured at 570 nm (SpectraMax 190 Absorbance 
Microplate Reader, Molecular Devices) and readings corrected for background 
measurement with a bacteria-free control. S. aureus 8325-4 (fibronectin binding) or 
S. aureus Newman (fibrinogen binding) were included as binding controls.42 
 
Cell culture adhesion and internalization assay 
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HaCaT cell line maintenance: The immortalized human keratinocyte cell line 
(HaCaT) was maintained at 37°C (5% CO2 atmospheric pressure) in T75 or T175 
flasks with DMEM medium (Lonza Ltd., Belgium), supplemented with 10% foetal calf 
serum (FCS) (First Link Ltd., UK) and 1% penicillin-streptomycin, 50 IU/ml (Life 
Technologies Inc., UK). 
Combined bacterial adhesion and invasion assay 
Bacterial adhesion and invasion of human epithelial cells was assayed as previously 
described 34,37,43 with the following modifications: Briefly, HaCaT cells (4.5 x 104 
cells/ml) were seeded onto circular glass coverslips (13 mm diameter, VWR 632-
0150) in 24-well tissue culture plates containing DMEM/10% FCS and 1% penicillin-
streptomycin and grown to 80-90% confluency. Bacterial cultures were grown at 
37°C in Brain Heart Infusion (BHI) broth to stationary phase, centrifuged, washed 
and re-suspended in DMEM/10% FCS without antibiotics. A 1 x 106 CFU/ml bacterial 
aliquot was added to each well of confluent HaCaT cells, incubated for 90 minutes at 
37°C (5% CO2), after which cells were carefully washed three times with PBS to 
remove non-adherend bacteria. The bacterial input CFU was checked for accuracy 
by serial dilution and plating onto BHI agar and colony counting after overnight 
incubation. For the combined adhesion and internalization assays, 0.5% trypsin 
(Worthington Biochemical Corp.) was added for 10 minutes at 37°C, to detach cells, 
and then neutralized with 1 ml DMEM/10% FCS. Cell suspensions were centrifuged 
(SIGMA 1-14 Microfuge, SciQuip Ltd.) at 14.800 rpm for 20 minutes and the mixed 
HaCaT/bacteria pellet resuspended in de-ionized water for 30 minutes to lyse the 
eukaryotic cells. Released bacteria were enumerated after overnight growth at 37°C 
on BHI agar to establish the proportion of both bound and internalized bacteria 
combined as CFU/ml. 
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Bacterial invasion assay: The internalization assays were performed as described for 
the combined adhesion and uptake assay, only that after the 90 minute co-
incubation of cells and bacteria and the three PBS washes, extracellular adhered 
and non-adhered bacteria were killed by adding 50 µg/ml lysostaphin in DMEM/10% 
FCS for 1 hour at 37°C. Externally killed bacteria were washed off using PBS. 
Detachment of HaCaT cells from the coverslip, cell lysis and bacterial enumeration 
of internalized bacteria was performed as described above. The HaCat cell viability, 
when incubated with 50 μg/ml lysostaphin for 1 hour and also the bacterial killing 
efficiency with 50 μg/ml lysostaphin was confirmed using the non-toxic alamarBlue® 
assay (Supplementary Material Figures S3 and S4). 
Bacterial adhesion assay: Bacterial adhesion was calculated by subtracting CFUs/ml 
obtained from the internalization assay from CFUs/ml obtained from the combined 
adhesion and internalization assay. The final percentage of adhesion and uptake 
was calculated in relation to the total CFU input for each bacterial strain. 
 
Chlorhexidine (CHG) killing efficiency  
The combined adhesion and internalization assay was performed as described 
above, to test for superficial CHG efficacy on a keratinocyte-MRSA co-culture. No 
differentiation between internalized and adhered bacteria was made. After washing 
off extracellular non-adhered bacteria, CHG was added to the Staphylococci/HaCaT 
cell co-culture at a final concentration of 6 mg/l and incubated at 37°C for 1 hour, 
followed by a final PBS wash to remove the CHG solution and non-adhered bacteria. 
Intracellular killed bacteria by CHG could not be eliminated at this point. Lysostaphin 
was not applied in this assay, as the CHG activity was investigated on adhered and 
internalized bacteria combined. The HaCat cell viability, when incubated with 6 
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mg/ml CHG, was confirmed using the non-toxic alamarBlue® assay (Supplementary 
Material, Figure S2). 
Detachment of HaCaT cells from the coverslip, cell lysis and bacterial enumeration 
of internalized and adhered bacteria was performed as described above. The final 
percentage of both, adhered and internalized bacteria surviving the CHG treatment 
was assessed in relation to the internalization and adhesion CFU result where no 
CHG was added, thus for each individual bacterial strain. The results for all strains 
belonging to the same clone were averaged and shown as the percentage CHG 
survival, representing the CHG efficacy. 
 
Electron microscopy – Visualization of adhered and internalized ST239-TW 
Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM) 
were performed on 4.5 × 104 HaCaT cells/ml grown to 80-90% confluency on 
Nunc™ Thermanox™ coverslips (Thermo Fisher Scientific Inc.) in a 24-well tissue 
culture plate at 37°C in 5% CO2. Eukaryotic cells were subsequently incubated with 
stationary phase grown ST239-TW (1 x 106 CFU/ml) for 90 minutes under the same 
growth conditions. HaCaT cell monolayers were washed three times with PBS to 
remove non-adhered bacteria, not followed by lysostaphin treatment, to allow 
visualization of adhered as well as internalized bacteria. 
For TEM, the epithelial monolayers were fixed with 2.5% (v/v) glutaraldehyde in 0.1M 
cacodylate buffer (pH 7.3) at 4°C for 4 hours. After rinsing thoroughly with cacodylate 
buffer, samples were post-fixed with 1% (w/v) osmium tetroxide in 0.1M cacodylate 
buffer (pH 7.3) for 1 hour at 4°C. Samples were then dehydrated through a graded 
ethanol series, equilibrated with propylene oxide before infiltration with TAAB epoxy 
resin and polymerised at 70°C for 24 hours. Ultrathin sections (50-70 nm) were 
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prepared using a Reichert-Jung Ultracut E ultramicrotome, mounted on 150 mesh 
copper grids and contrasted using uranyl acetate and lead citrate. Samples were 
examined on an FEI Tecnai 12 transmission microscope operated at 120 kV and 
images were acquired with an AMT 16000M camera.  
For SEM, the HaCaT cell monolayers were fixed with 4% (v/v) paraformaldehyde. 
Before further processing, the samples were placed into 3% (v/v) glutaraldehyde in 
0.1M cacodylate buffer (pH 7.3) and incubated for 24 hours. Finally, the samples 
were dehydrated for 10 minutes each in 20, 50, 70 and 90% ethanol, followed by 30 
minutes incubation in 100% ethanol and a final drying step using 
hexamethyldisilazane. The samples were mounted onto stubs with a conducting 
carbon cement applied between, coated with gold and the images assessed with an 
FEI Quanta 3D FEG scanning electron microscope. 
 
Statistical methods 
All experiments were performed on six ST36, six ST22 and six ST239-TW isolates, 
where each isolate was tested in triplicates on at least two independent occasions 
and the results shown as the average derived from all strains per clonal group. 
Statistical analysis was performed using GraphPad Prism 6.0 software. The two 
tailed non-parametric t test (Mann-Whitney ranked sum test) was applied to find 
differences between ST239-TW to ST22 and ST36 and the control strains, as well as 
qacA+ and qacA- strains (MICs). Minimum statistical significance was set to P < 0.05. 
 
RESULTS 
Chlorhexidine (CHG) MICs  
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Six qacA+ ST239-TW, three qacA+ and three qacA- ST36 and ST22 MRSA BSI 
isolates with comparable low MICs (Supplementary Material Table S4) were 
randomly selected from an initial 136 isolate cohort 12 and multiple replicate CHG 
testing performed to verify their initially established MICs (Table 1). Re-testing 
showed only minor differences in the clones’ CHG susceptibilities compared to 2013 
(Supplementary Material Table S4). The highest change in MIC was found for the 
ST22 clones, showing an increase of 45% compared to 2013. MICs of qacA+ and 
qacA- ST36 and ST22 clones (1.75 mg/l ± 0.05 vs 1.47 mg/l ± 0.08, P = 0.29) were 
similar. The fact that all ST239-TW isolates from the initial cohort were qacA+ needs 
to be noted. These results confirm the 2013 established low MICs and imply that 
qacA carriage alone cannot explain the in vivo chlorhexidine survival of ST239-TW at 
the intensive care unit (ICU) of Guy’s and Thomas' Hospital. So, we investigated cell 
adhesion and uptake as an additional explanation for their survival under topically 
applied chlorhexidine pressure in a clinical setting. 
 
Protein binding assay 
Binding of MRSA clones to fibrinogen and fibronectin at stationary and exponential 
growth phases was first investigated (Figure 1). In general, protein binding was 
either equal or higher at stationary than at exponential bacterial growth phase. There 
were however clear differences between protein binding of the clonal groups in each 
growth phase. ST239-TW binding to both fibrinogen (OD570nm absorption: 
stationary 0.192; exponential 0.165) and fibronectin (stationary 0.350; exponential 
0.172) was significantly higher than for ST22, ST36 and the control strains (P < 
0.001) at exponential and stationary growth phases, with the exception of ST36 at 
exponential growth (fibronectin 0.077, P = 0.195; fibrinogen 0.089, 0.175, P = 0.211). 
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Adhesion to and internalization into human keratinocytes 
Adherence and internalization of MRSA clones was assessed in vitro using an 
immortalized keratinocyte cell line (HaCaT) (Figure 2). Here, only the adhesion and 
invasion propensities between the three clones was investigated, and not their 
survival or persistence, to provide preliminary data for further CHG effectiveness 
testing on S. aureus bound and internalized to HaCaT cells. The co-culture 
incubation time was set to 90 minutes only, to minimize HaCaT cell degradation and 
apoptotic processes. 
Electron micrographs of HaCaT cells inoculated with the representative isolate 
ST239-TW (TW20), confirmed bacterial adhesion and internalization (Figure 3) to 
HaCaT cells. TW20 bacteria were found on the keratinocyte surface (SEM) and 
during different stages of internalization (TEM – cross section of co-cultured bacteria 
with HaCaT cells), either in the process of binding, inside the epithelial cells 
enclosed within vacuoles, or appearing in the cell cytosol. No quantitative 
assessment was made. 
The percentage of inoculated ST239-TW, then binding to HaCaT cells (16.39%) was 
significantly greater than for ST22 (9.44%; P = 0.0021) and ST36 (4.73%; P < 
0.0001). Also, with 0.41%, a greater proportion of inoculated ST239-TW bacteria 
internalized into keratinocytes than ST22 (0.22%; P = 0.0126) and ST36 (0.09%; P < 
0.0001).  
 
Chlorhexidine (CHG) efficacy on co-adhered and internalized MRSA to 
keratinocytes 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
CHG at 6 mg/l, which is more than twice the MIC of all tested MRSA clones (Table 1), 
resulted in 100% killing of bacteria without HaCaT cells (data not shown) and had 
only minimal cytotoxic effect on the HaCaT cell viability over 4 hours of incubation 
when tested without bacteria (Supplementary Material Figure S2).  
CHG treatment, of infected (bound and internalized bacteria) monolayers showed 
about a three-fold greater recovery of ST239-TW (12.79% survival; P < 0.001) 
compared with ST22 (3.18%) and ST36 (4.57%), but all three clinical clones were 
less likely to be killed by CHG than the control strains S. aureus Newman and S. 
aureus 8325-4 (< 0.7%; P < 0.0001) (Table 2). 
 
DISCUSSION 
The widespread use of biocides for decolonization has become an important 
infection control intervention to decrease transmission of nosocomial pathogens, but 
has also raised concerns about the development of bacterial biocide 
tolerance.13,16,44,45 Here we show evidence that bacterial uptake into skin cells 
together with extracellular adherence can protect some MRSA clones against 
biocide action. This provides a putative mechanism whereby ST239-TW was able to 
resist chlorhexidine when introduced on the ICU of GSTT, in the absence of a 
measurable difference in MIC. Although it had previously been suggested that qacA 
and B carriage confers chlorhexidine tolerance,15–17 our results can only partially 
support this. However, any effects of subtle increases of CHG MIC on ST239-TW 
internalized and adhered to keratinocytes were not evaluated and further, no 
distinction between qacA+ and qacA- isolates was possible. An alternative 
mechanism suggested by our data is that ST239-TW has a selective advantage 
compared to ST22 and ST36 clones during topical chlorhexidine treatment due to its 
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enhanced ability to bind and invade skin cells. A further possibility, though not 
investigated here, is the correlation of qacA/B carriage with an agr (quorum-sensing 
operon) dysfunction, recently described by Cho et al., suggesting a selection 
advantage of ST239 clones over others in an ICU with common chlorhexidine 
usage.46 
 
Staphylococcal adhesion, invasion and persistence has been observed in multiple 
human cell types and has been postulated as a means of evading the host innate 
immunity and antibiotic action, leading to either recurrent or chronic infections.28–32 
However, the preliminary findings presented here support an additional hypothesis 
that by invading and adhering to skin cells, S. aureus (ST239-TW) is also protected 
against the important infection control intervention of chlorhexidine decolonization in 
healthcare settings. Binding to fibrinogen and fibronectin are key steps in 
staphylococcal adhesion and invasion, and thus are of relevance in disease 
pathogenesis.34–37 We found that compared with ST22 and ST36, ST239-TW 
showed increased binding to fibrinogen and fibronectin, and increased adherence 
and internalization into keratinocyte monolayers. This supports the clinical 
phenomenon of in vivo chlorhexidine survival. However, we must note that common 
experimental investigations for S. aureus and eukaryotic cell interactions in vitro 
perform co-incubation for around one hour,34,37,43 which does not fully represent a 
long-term clinical exposure to MRSA, but certainly allows for the identification of 
differences between MRSA clones, whilst minimizing cell apoptotic side effects.43,47 
The previous finding that some ST239 clones exhibit increased colonization potential 
to human nasal epithelial cells due to carriage of sasX, a mobile genetic element–
encoded gene 48 also carried by ST239-TW 49 but not tested in this study, provides 
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supporting evidence that host cell linked CHG survival, as also shown elsewhere 28–
31 is an important virulence mechanism of this clone. 
 
Persistent skin colonization during antiseptic decolonization is a concern not only for 
patients on ICUs. It could enable colonization of catheters leading to bacteremia 50 
and colonization of healthcare workers’ hands facilitating transmission to other 
patients.14 Chlorhexidine is used extensively in hospitals for skin cleansing prior to 
invasive procedures and to remove antimicrobial resistant bacteria to prevent 
transmission or infection. 51–53 However, skin traumas which are often present in ICU 
patients due to surgery, intubation or intravenous catheter insertion, allow the 
exposure of extracellular matrix proteins on the epithelial surface, thus presenting 
excellent initial binding conditions for MRSA isolates. Indeed, the ST239-TW MRSA 
strains tested in this study showed elevated survival to CHG in vitro when adhered 
and internalized to keratinocyte monolayers. Similarly Lehar et al. showed that a 
minority of MRSA can actually survive in macrophages, even under antibiotic 
pressure, and retain their ability to establish infections.32  
 
Recent clinical studies have observed high rates of qacA carriage by Staphylococci 
including those isolated from healthcare workers, and in some studies that has been 
linked with extensive chlorhexidine use.54,55 Connecting multi-drug efflux pumps such 
as the one encoded by qacA to a decreased staphylococcal susceptibility against 
cationic antiseptic agents (e.g. chlorhexidine) seems to be reasonable, but remains 
controversial.15,16,20,21,45 In contrast with previous findings, showing a two- to four-fold 
increase in chlorhexidine MBC of five tested qacA+ ST239-TW skin isolates,13 no 
conclusion could be drawn from our ST239-TW BSI isolates, since all strains 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
specifically selected, had a moderate MIC below 2 mg/l, despite being qacA+. It is 
possible that the elevated MBC phenotype from skin isolates analyzed shortly after 
the outbreak at GSTT may have been lost after storage. Conversely, serial 
passaging of six ST239-TW isolates whilst exposed to sub-inhibitory CHG 
concentrations in vitro did not increase their MICs (Supplementary Material Figure 
S1). Consistent with other studies, we showed that biocide activity is not, or only 
partially affected by the presence of a S. aureus efflux pump.18,19,21 Nevertheless, we 
cannot exclude that qacA carriage plays a role in the in vivo ST239-TW 
chlorhexidine tolerance phenotype.13,50 It remains possible that unknown factors are 
required to demonstrate the chlorhexidine resistance phenotype of qacA+ strains in 
the laboratory. 
 
The findings presented here provide evidence to support the hypothesis that the 
clinical chlorhexidine phenotype (in vivo decolonization tolerance) of some MRSA 
clones may be due to adhesion and intracellular invasion of keratinocytes. However, 
further experiments will be required, with prolonged chlorhexidine exposure and 
antibiotic co-treatment  in primary cell cultures and skin models 56,57 to examine the 
effects of keratinocyte antimicrobial peptides, 58 and to extend our findings by 
identifying the bacterial factors involved in protection against chlorhexidine and 
additionally investigate the consequences of intracellular survival on the host cells. 
Also, the relative importance of adhesion versus internalization and whether this 
phenomenon is associated with other clones with a similar in vivo phenotype needs 
to be established. Although our findings need further investigation, we feel that there 
is compelling evidence that the host cell invasion mechanism employed by MRSA 
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strains to evade innate immunity also confers tolerance to infection control 
interventions, which is of high clinical importance. 
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Tables 
Table 1. Chlorhexidine (CHG) MICs for selected representative EMRSA BSI isolates  
Clone Isolates (n) MIC mean [mg/l]   ±  SEM MIC range [mg/l] 
ST239-TW 6 1.29 ± 0.18 1.0 - 1.5 
 
ST22 6 2.68 ± 0.53 1.9 - 3.3 
 
ST36 6 1.61 ± 0.18 1.4 - 1.8 
 
S. aureus 8325-4 1 0.75 ± 0.25 0.1 - 1.0 
S. aureus Newman 1 1.13 ± 0.13 1.0 - 2.0 
S. aureus NCTC 10788 1 0.97 ± 0.18 0.3 - 1.0 
Abbreviations: MIC, minimum inhibitory concentration; EMRSA, epidemic methicillin-
resistant Staphylococcus aureus; SEM, standard error of the mean. 
Note: Results are the means of ≥3 independent experiments of each individual 
isolate, tested in triplicate. 
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Table 2. Killing effect of chlorhexidine (CHG) on adherent and internalized MRSA 
clones co-cultures with HaCaT cells. 
Clone % bacterial survival P 95% CI 
ST239-TW 12.79 ± 1.08  10.34 to 14.02 
ST22 3.18 ± 0.76  *** 1.44 to 4.15 
ST36 4.57 ± 1.68 *** 1.19 to 5.20 
S. aureus Newman 0.13 ± 0.03  *** 0.07 to 0.19 
S. aureus 8325-4  0.66 ± 0.26 *** 0.06 to 1.25 
Note: Results of six ST36, six ST22 and six ST239-TW isolates are for ≥2 
independent experiments performed in triplicate and are presented as the mean and 
standard error of the mean percentage recovery for each clone; ***P < 0.001; [non-
parametric two tailed Mann Whitney U test compared to ST239-TW]. 
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Figures 
 
Figure 1. Bacterial binding to immobilized human fibrinogen (A) and 
fibronectin (B) at stationary (filled bars) exponential (open bars) growth 
phases. Bars show the results for ≥3 independent experiments performed in 
triplicate (S. aureus Newman, S. aureus 8325-4, six ST36, six ST22 and six ST239-
TW isolates) with the standard error of the mean for each clonal group. *P < 0.05, 
***P < 0.001; [Non-parametric two tailed Mann Whitney U test compared to ST239-
TW]. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Figure 2. Adherence (filled bars) and internalization (open bars) of MRSA 
clones to HaCaT cells.  
Results are shown for ≥3 independent experiments performed in triplicate (S. aureus 
Newman, S. aureus 8325-4, six ST36, six ST22 and six ST239-TW isolates) with the 
standard error of the mean for each clonal group. *P < 0.05, **P < 0.01, ***P < 0.001; 
[Non-parametric two tailed Mann Whitney U test compared to ST239-TW]. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Figure 3. Electron micrographs of HaCaT cells infected with MRSA ST239-TW strain 
(TW20)59. SEM (A, B) of adhered ST239-TW and TEM (C, D) of surrounding, and 
internalized ST239-TW, either presenting in vacuoles or embedded in the cell 
cytoskeleton. SEM shows the top view and TEM a cross section of co-incubated 
HaCaT cells with ST239-TW (TW20) bacteria for one hour and a three time wash 
with PBS. 
 
 
